Literature DB >> 24531980

Erdheim-Chester disease with an 18F-fluorodeoxyglucose-avid breast mass and BRAF V600E mutation.

Toshihiro Furuta1, Shigeru Kiryu, Haruyasu Yamada, Masataka Hosoi, Mineo Kurokawa, Teppei Morikawa, Junji Shibahara, Kuni Ohtomo.   

Abstract

Erdheim-Chester disease (ECD) is a non-Langerhans cell histiocytosis. Herein we report a case of a 49-year-old woman who developed bilateral knee pain. Imaging procedures revealed multiple long bone lesions and a well-defined 18F-fluorodeoxyglucose-avid mass in the left breast. The breast mass was resected, and an open biopsy was performed on the right femoral lesion. Both specimens revealed involvement by histiocytic infiltrates with features suggestive of ECD. The BRAF V600E mutation was detected by DNA sequencing and immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24531980     DOI: 10.1007/s11604-014-0295-z

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  9 in total

1.  Pseudotumoral bilateral involvement of the breast in Erdheim-Chester disease: CT appearance.

Authors:  F Ferrozzi; D Bova; G Tognini; G Zuccoli
Journal:  J Comput Assist Tomogr       Date:  2000 Mar-Apr       Impact factor: 1.826

2.  Erdheim-Chester disease of the breast associated with Langerhans-cell histiocytosis of the hard palate.

Authors:  V P Andrade; C C V Nemer; A N L Prezotti; W S L Goulart
Journal:  Virchows Arch       Date:  2004-08-24       Impact factor: 4.064

3.  Erdheim-Chester disease of the breast: a case report and review of the literature.

Authors:  Penny J Barnes; Annette Foyle; Kelly A Dakin Haché; Richard G B Langley; Steven Burrell; Ridas Juskevicius
Journal:  Breast J       Date:  2005 Nov-Dec       Impact factor: 2.431

Review 4.  Erdheim-Chester Disease: a comprehensive review of the literature.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Yehuda Shoenfeld
Journal:  Orphanet J Rare Dis       Date:  2013-09-08       Impact factor: 4.123

5.  High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

Authors:  Julien Haroche; Frédéric Charlotte; Laurent Arnaud; Andreas von Deimling; Zofia Hélias-Rodzewicz; Baptiste Hervier; Fleur Cohen-Aubart; David Launay; Annette Lesot; Karima Mokhtari; Danielle Canioni; Louise Galmiche; Christian Rose; Marc Schmalzing; Sandra Croockewit; Marianne Kambouchner; Marie-Christine Copin; Sylvie Fraitag; Felix Sahm; Nicole Brousse; Zahir Amoura; Jean Donadieu; Jean-François Emile
Journal:  Blood       Date:  2012-08-09       Impact factor: 22.113

6.  Erdheim-chester disease presenting as bilateral clinically malignant breast masses.

Authors:  Elena Provenzano; Susan J Barter; Penelope A Wright; Parto Forouhi; Richard Allibone; Ian O Ellis
Journal:  Am J Surg Pathol       Date:  2010-04       Impact factor: 6.394

Review 7.  Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases.

Authors:  C Veyssier-Belot; P Cacoub; D Caparros-Lefebvre; J Wechsler; B Brun; M Remy; B Wallaert; H Petit; A Grimaldi; B Wechsler; P Godeau
Journal:  Medicine (Baltimore)       Date:  1996-05       Impact factor: 1.889

8.  Erdheim-Chester disease involving breast and muscle: imaging findings.

Authors:  A P Tan; L K Tan; I H Choo
Journal:  AJR Am J Roentgenol       Date:  1995-05       Impact factor: 3.959

9.  18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease.

Authors:  Laurent Arnaud; Zoulikha Malek; Frédérique Archambaud; Aurélie Kas; Dan Toledano; Aurélie Drier; Delphine Zeitoun; Philippe Cluzel; Philippe A Grenier; Jacques Chiras; Jean-Charles Piette; Zahir Amoura; Julien Haroche
Journal:  Arthritis Rheum       Date:  2009-10
  9 in total
  1 in total

1.  A rare case of Erdheim-Chester disease in the breast.

Authors:  Razan F Binyousef; Aboelkhair M Al-Gahmi; Zahid Rahman Khan; Elham Rawah
Journal:  Ann Saudi Med       Date:  2017 Jan-Feb       Impact factor: 1.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.